Research Papers

25 of 85 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2.
Purbey PK; Roy K; Gupta S; Paul MK.
Mol Immunol (Unknown)
Published: 2023
1/6 Transparent
Synergism of TNF-α and IFN-β triggers human airway epithelial cells death by apoptosis and pyroptosis.
Sun R; Jiang K; Zeng C; Zhu R; Chu H; Liu H; Du J.
Mol Immunol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Identification of virus-specific B-cell epitopes by convalescent plasma from COVID-19 patients.
Wang L; Zhao J; Schank M; Khanal S; Dang X; Cao D; Nguyen LNT; Zhang Y; Wu XY; Adkins JL; Brueggeman J; Zhang J; Ning S; El Gazzar M; Moorman JP; Yao ZQ.
Mol Immunol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease prog…
Urwyler P; Moser S; Trendelenburg M; Sendi P; Osthoff M.
Mol Immunol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Influence of SARS-CoV-2 inactivation by different chemical reagents on the humoral response evaluated in a murine model.
de Castro Barbosa E; de Souza Andrade A; Duarte MM; Faria G; de Melo Iani FC; Ataide ACZ; Cunha LM; Duarte CG; Fialho SL; Caldas S.
Mol Immunol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Humoral response to the BBIBP-CorV vaccine over time in healthcare workers with or without exposure to SARS-CoV-2.
Badano MN; Sabbione F; Keitelman I; Pereson M; Aloisi N; Colado A; Ramos MV; Ortiz Wilczyñski JM; Pozner RG; Castillo L; Wigdorovitz G; E de Bracco MM; Fink S; Chuit R; Baré P.
Mol Immunol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Generation and utility of a single-chain fragment variable monoclonal antibody platform against a baculovirus expressed…
Salem R; El-Kholy AA; Waly FR; Ayman D; Sakr A; Hussein M.
Mol Immunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
The glycosylation status of MHC class I molecules impacts their interactions with TAPBPR.
Ilca FT; Boyle LH.
Mol Immunol (Unknown)
Published: 2021
1/6 Transparent
Funding Declared
Access to ultra-long IgG CDRH3 bovine antibody sequences using short read sequencing technology.
Oyola SO; Henson SP; Nzau B; Kibwana E; Nene V.
Mol Immunol (Unknown)
Published: 2021
4/6 Transparent
Data Funding Declared
Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progres…
Mahmoodpoor A; Hosseini M; Soltani-Zangbar S; Sanaie S; Aghebati-Maleki L; Saghaleini SH; Ostadi Z; Hajivalili M; Bayatmakoo Z; Haji-Fatahaliha M; Babaloo Z; Farid SS; Heris JA; Roshangar L; Rikhtegar R; Kafil HS; Yousefi M.
Mol Immunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
Mohkhedkar M; Venigalla SSK; Janakiraman V.
Mol Immunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection.
Balkhi MY.
Mol Immunol (Unknown)
Published: 2021
1/6 Transparent
Research in non-rodent vertebrates enlightens the immunological landscape.
Meurens F; Bertho N.
Mol Immunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Potential therapeutic effects of interleukin-35 on the differentiation of naïve T cells into Helios<sup>+</sup>Foxp3<su…
Wang C; Xie K; Li K; Lin S; Xu F.
Mol Immunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Death associated protein kinase 2 suppresses T-B interactions and GC formation.
Ni X; Wang Y; Wang P; Chu C; Xu H; Hu J; Sun J; Qi H.
Mol Immunol (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Jigsaw falling into place: A review and perspective of lymphoid tissue CD8+ T cells and control of HIV.
Nguyen S; Sada-Japp A; Petrovas C; Betts MR.
Mol Immunol (Unknown)
Published: 2020
1/6 Transparent
Funding Declared
Transcriptional regulation of DC fate specification.
Bosteels C; Scott CL.
Mol Immunol (Unknown)
Published: 2020
1/6 Transparent
Funding Declared
Effect of TLR agonist on infections bronchitis virus replication and cytokine expression in embryonated chicken eggs.
Sharma BK; Kakker NK; Bhadouriya S; Chhabra R.
Mol Immunol (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Camelid type I interferons: Identification and functional characterization of interferon alpha from the dromedary camel…
Premraj A; Aleyas AG; Nautiyal B; Rasool TJ.
Mol Immunol (Unknown)
Published: 2020
3/6 Transparent
Data Funding Declared
Deiminated proteins in extracellular vesicles and serum of llama (Lama glama)-Novel insights into camelid immunity.
Criscitiello MF; Kraev I; Lange S.
Mol Immunol (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Anti-inflammatory activity of intravenous immunoglobulin through scavenging of heme.
Wiatr M; Merle NS; Boudhabhay I; Poillerat V; Rossini S; Lecerf M; Kaveri SV; Lacroix-Desmazes S; Roumenina LT; Dimitrov JD.
Mol Immunol (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Tumor suppressor p53 inhibits porcine epidemic diarrhea virus infection via interferon-mediated antiviral immunity.
Hao Z; Fu F; Cao L; Guo L; Liu J; Xue M; Feng L.
Mol Immunol (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Production, purification, and evaluation of quail immunoglobulin Y against Salmonella typhimurium and Salmonella enteri…
Esmailnejad A; Abdi-Hachesoo B; Hosseini Nasab E; Shakoori M.
Mol Immunol (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Neutrophils: Homing in on the myeloid mechanisms of metastasis.
Leach J; Morton JP; Sansom OJ.
Mol Immunol (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Critical assessment of approaches for molecular docking to elucidate associations of HLA alleles with adverse drug reac…
Ramsbottom KA; Carr DF; Jones AR; Rigden DJ.
Mol Immunol (Unknown)
Published: 2018
2/6 Transparent
Funding Declared